These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32322781)

  • 1. Peritoneal Carcinomatosis in Well-Differentiated Small-Intestinal Neuroendocrine Tumors with Mesenteric Tumor Deposits.
    Das S; Shi C; Koyama T; Huang Y; Gonzalez R; Idrees K; Bailey CE; Berlin J
    J Med Surg Pathol; 2019; 4(1):1-10. PubMed ID: 32322781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel.
    Grillo F; Albertelli M; Malandrino P; Dotto A; Pizza G; Cittadini G; Colao A; Faggiano A
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3209-3221. PubMed ID: 35639999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
    Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
    Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
    Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
    Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors.
    Gonzalez RS; Cates JMM; Shi C
    Mod Pathol; 2018 Oct; 31(10):1560-1566. PubMed ID: 29795438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna.
    Melhorn P; Kretschmer-Chott E; Wolff L; Haug A; Mazal P; Raderer M; Kiesewetter B
    Ther Adv Med Oncol; 2022; 14():17588359221138389. PubMed ID: 36425874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of Small Intestinal Neuroendocrine Tumors Metastasis: Biologic Patterns of a Series with Virchow's Node Involvement.
    Wedin M; Tsoli M; Wallin G; Janson ET; Koumarianou A; Kaltsas G; Daskalakis K
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
    Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
    World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors.
    de Mestier L; Lardière-Deguelte S; Brixi H; O'Toole D; Ruszniewski P; Cadiot G; Kianmanesh R
    Neuroendocrinology; 2015; 101(2):105-11. PubMed ID: 25592061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?
    Gonzalez RS; Liu EH; Alvarez JR; Ayers GD; Washington MK; Shi C
    Mod Pathol; 2014 Sep; 27(9):1288-95. PubMed ID: 24457461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options.
    Merola E; Prasad V; Pascher A; Pape UF; Arsenic R; Denecke T; Fehrenbach U; Wiedenmann B; Pavel ME
    Neuroendocrinology; 2020; 110(6):517-524. PubMed ID: 31484182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer.
    Nasser S; Babayeva A; Braicu I; Richter R; Bilir E; Chekerov R; Muallem MZ; Pietzner K; Inci MG; Sehouli J
    Front Oncol; 2022; 12():1014073. PubMed ID: 36620574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Surgical Management Strategies in the Treatment of Peritoneal Carcinomatosis of Neuroendocrine Origin.
    Fallows M; Samant A; Wilson H; Mirnezami R
    Curr Oncol; 2023 Jul; 30(7):6316-6329. PubMed ID: 37504326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women.
    Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Oudijk L; de Herder WW; Hofland LJ; Feelders RA
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1969-e1975. PubMed ID: 34999838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
    Roberts J; Gonzalez RS; Revetta F; Shi C
    Histopathology; 2018 Nov; 73(5):795-800. PubMed ID: 29943407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor.
    Wright MF; Cates J; Gonzalez RS; Das S; Berlin JD; Shi C
    Am J Surg Pathol; 2019 Apr; 43(4):559-563. PubMed ID: 30702499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual PET/CT scoring of mesenteric fdg uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis.
    Wang SB; He H; Xv DD; She B; Lu RC; Yang ZH; Shi H; Xie R
    Diagn Interv Radiol; 2020 Nov; 26(6):523-530. PubMed ID: 32558647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting symptomatic mesenteric mass in small intestinal neuroendocrine tumors using radiomics.
    Blazevic A; Starmans MPA; Brabander T; Dwarkasing RS; van Gils RAH; Hofland J; Franssen GJH; Feelders RA; Niessen WJ; Klein S; de Herder WW
    Endocr Relat Cancer; 2021 Jun; 28(8):529-539. PubMed ID: 34003139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis.
    Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Franssen GJH; Feelders RA; Zajec M; Luider TM; de Herder WW; Hofland LJ
    Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36951556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.